Balyasny Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-324,487
| Closed | -$7.1M | – | 1974 |
|
|
2025
Q1 | $7.1M | Sell |
324,487
-419,707
| -56% | -$9.18M | 0.01% | 767 |
|
|
2024
Q4 | $23.7M | Buy |
+744,194
| New | +$23.7M | 0.04% | 448 |
|
|
2024
Q3 | – | Sell |
-199,954
| Closed | -$7.67M | – | 1936 |
|
|
2024
Q2 | $7.67M | Sell |
199,954
-32,289
| -14% | -$1.24M | 0.01% | 713 |
|
|
2024
Q1 | $13.7M | Buy |
+232,243
| New | +$13.7M | 0.02% | 596 |
|
|
2023
Q3 | – | Sell |
-304,169
| Closed | -$27.7M | – | 1748 |
|
|
2023
Q2 | $27.7M | Sell |
304,169
-313,728
| -51% | -$28.6M | 0.06% | 353 |
|
|
2023
Q1 | $40.8M | Buy |
617,897
+361,556
| +141% | +$23.8M | 0.1% | 220 |
|
|
2022
Q4 | $13.3M | Buy |
256,341
+209,076
| +442% | +$10.8M | 0.04% | 505 |
|
|
2022
Q3 | $3.23M | Buy |
+47,265
| New | +$3.23M | 0.01% | 938 |
|
|
2022
Q1 | – | Sell |
-128,514
| Closed | -$6.08M | – | 2099 |
|
|
2021
Q4 | $6.08M | Sell |
128,514
-54,633
| -30% | -$2.58M | 0.02% | 664 |
|
|
2021
Q3 | $6.04M | Buy |
+183,147
| New | +$6.04M | 0.03% | 625 |
|
|
2018
Q4 | – | Sell |
-60,000
| Closed | -$1.07M | – | 1261 |
|
|
2018
Q3 | $1.07M | Sell |
60,000
-5,428
| -8% | -$96.5K | ﹤0.01% | 952 |
|
|
2018
Q2 | $1.44M | Buy |
+65,428
| New | +$1.44M | 0.01% | 869 |
|